002773 康弘药业
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额539,7721,503,6481,411,8751,218,411925,153
投资活动产生之现金流量净额(3,061,331)(225,367)(112,056)6,616(215,553)
筹资活动产生之现金流量净额(500,864)(519,523)(344,139)(130,498)(73,851)
汇率变动对现金及现金等价物的影响(248)(483)(246)(212)987
现金及现金等价物净增加/(减少)(3,022,670)758,276955,4331,094,318636,736
期初现金及现金等价物余额6,383,7035,625,4274,669,9943,575,6762,938,940
期末现金及现金等价物余额3,361,0336,383,7035,625,4274,669,9943,575,676